Intervention Review

Artesunate versus quinine for treating severe malaria

  1. David Sinclair1,*,
  2. Sarah Donegan1,
  3. David G Lalloo2

Editorial Group: Cochrane Infectious Diseases Group

Published Online: 16 MAR 2011

Assessed as up-to-date: 30 JAN 2011

DOI: 10.1002/14651858.CD005967.pub3

How to Cite

Sinclair D, Donegan S, Lalloo DG. Artesunate versus quinine for treating severe malaria. Cochrane Database of Systematic Reviews 2011, Issue 3. Art. No.: CD005967. DOI: 10.1002/14651858.CD005967.pub3.

Author Information

  1. 1

    Liverpool School of Tropical Medicine, International Health Group, Liverpool, UK

  2. 2

    Liverpool School of Tropical Medicine, Clinical Research Group, Liverpool, Merseyside, UK

*David Sinclair, International Health Group, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool, L3 5QA, UK. davesinkers@yahoo.com.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 MAR 2011

SEARCH

  1. Current Version

    Artesunate versus quinine for treating severe malaria

    David Sinclair, Sarah Donegan and David G Lalloo

    Article first published online: 16 MAR 2011 | DOI: 10.1002/14651858.CD005967.pub3

Previous versions of this article and their online publication dates

  1. Version 2

    Artesunate versus quinine for treating severe malaria

    Katharine L Jones, Sarah Donegan and David G Lalloo

    Article first published online: 20 JAN 2010 | DOI: 10.1002/14651858.CD005967.pub2

  2. Version 1

    Artesunate versus quinine for treating severe malaria

    KL Jones, S Donegan and D Lalloo

    Article first published online: 18 JUL 2007 | DOI: 10.1002/14651858.CD005967